4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-21-070895
Chairman and CEO bought 10,650 shares at an average $1.50 ($15,929)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2021-12-17 | Purchase | +2,750 | $1.49 | $4,098 | 11,109,056 | D |
| Niihara Yutaka Chairman and CEO | 2021-12-20 | Purchase | +3,000 | $1.51 | $4,530 | 11,112,056 | D |
| Niihara Yutaka Chairman and CEO | 2021-12-21 | Purchase | +4,900 | $1.49 | $7,301 | 11,116,956 | D |
| Open-market purchases · 10,650 sh · avg $1.50 · $15,929 | |||||||
Loading xslF345X03/doc4.xml…